E-LIB Suche - Ergebnisse für: AstraZeneca

1

Erster SGLT-2-Inhibitor erhält CHMP-Emfehlung:

AstraZeneca ; Bristol-Myers Squibb
MMW - Fortschritte der Medizin. 154 (2012) 9 - p. 77-77 , 2012

Link: https://doi.org/10.1007/..

2

Sufficient control of heartburn in endoscopy negative heart..:

Junghard, Ola ; Carlsson, Rolf ; Lind, Tore.
Gastroenterology. 120 (2001) 5 - p. A402 , 2001

Link: https://doi.org/10.1016/..

3

Comparison of the ARMS and ASO test for K-ras mutations wit..:

Heek, Tjarda N. ; Clayton, Simon J. ; AstraZeneca...
Gastroenterology. 120 (2001) 5 - p. A608-A609 , 2001

Link: https://doi.org/10.1016/..

4

Sufficient control of heartburn in endoscopy negative heart..:

JUNGHARD, O ; CARLSSON, R ; LIND, T.
Gastroenterology. 120 (2001) 5 - p. A402-A402 , 2001

Link: https://doi.org/10.1016/..

5

Health-related quality of life improves with GERD symptom r..:

ZODET, M ; JOSHUAGOTLIB, S ; ASTRAZENECA, L...
Gastroenterology. 120 (2001) 5 - p. A402-A402 , 2001

Link: https://doi.org/10.1016/..

6

Drug interaction studies of esomeprazole with amoxicillin a..:

ANDERSSON, T ; ASTRAZENECA, L ; ROHSS, K.
Gastroenterology. 120 (2001) 5 - p. A581-A581 , 2001

Link: https://doi.org/10.1016/..

7

Comparison of the ARMS and ASO test for K-ras mutations wit..:

HEEK, T ; CLAYTON, S ; ASTRAZENECA...
Gastroenterology. 120 (2001) 5 - p. A608-A609 , 2001

Link: https://doi.org/10.1016/..

8

Health-related quality of life improves with GERD symptom r..:

Zodet, Marc W. ; Joshua-Gotlib, Sandra ; AstraZeneca, L.P....
Gastroenterology. 120 (2001) 5 - p. A402 , 2001

Link: https://doi.org/10.1016/..

9

Drug interaction studies of esomeprazole with amoxicillin a..:

Andersson, Tommy ; AstraZeneca, L.P. ; Rohss, Kerstin.
Gastroenterology. 120 (2001) 5 - p. A581 , 2001

Link: https://doi.org/10.1016/..

10

Outcome of Initial Antibiotic Treatments Among Hospitalized..:

Karve, Sudeep ; Ryan, Kellie ; Gaithersburg, AstraZeneca...
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..

11

Demographic characteristics as predictors of responses to t..:

Vakil, Nimish B. ; Katz, Philiip O. ; Hwang, Clara..
Gastroenterology. 120 (2001) 5 - p. A422-A423 , 2001

Link: https://doi.org/10.1016/..

12

Willingness to pay for relief of gastroesophageal reflux di..:

Kleinman, Leah ; Crawley, Joseph ; L.P., AstraZeneca...
Gastroenterology. 120 (2001) 5 - p. A402 , 2001

Link: https://doi.org/10.1016/..

13

Indian Phenotype Characteristics Among Patients with Type 2..:

AstraZeneca Pharma India Ltd, Bengaluru, India ; Department of Endocrinology, Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, India ; Department of Endocrinology, Ramaiah Medical College, Bengaluru, India...
Endocrinology. 18 (2022) 1 - p. 63 , 2022

Link: https://doi.org/10.17925..

14

"AstraZeneca Canada Inc. v. Apotex Inc.": Decision of the S..:

AstraZeneca Canada Inc., AstraZeneca Aktiebolag and AstraZeneca UK Limited v. Apotex Inc. and Apotex Pharmachem Inc. Patent Act, R.S.C. 1985, c. P-4, Sec. 2
IIC - International Review of Intellectual Property and Competition Law. 48 (2017) 7 - p. 864-865 , 2017

Link: https://doi.org/10.1007/..

15

Convenio de col·laboración entre Barcelona Activa y Astraze..:

Barcelona Activa, S.A ; AstraZeneca (Firma)
Gaseta Municipal de Barcelona (17-01-2023). , 2023

Link: http://hdl.handle.net/11..